Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction
about
Vasopressors and predominantly vasoconstrictive drugs for acute myocardial infarction complicated by cardiogenic shockInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeThe challenges in the management of right ventricular infarction.A team-based approach to patients in cardiogenic shock.Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.Evaluating surrogate marker information using censored data.Outcome after surgery and percutaneous intervention for cardiogenic shock and left main diseaseRisk stratification for ST segment elevation myocardial infarction in the era of primary percutaneous coronary intervention.Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry.Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry.Mechanical circulatory support in cardiogenic shock - what every interventional cardiologist should know.Effectiveness of percutaneous coronary intervention within 12 hours to 28 days of ST-elevation myocardial infarction in a real-world Chinese population.Long-term survival after mitral valve surgery for post-myocardial infarction papillary muscle ruptureDe novo acute heart failure and acutely decompensated chronic heart failureIn-Hospital Outcome of Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Results from Royal Hospital Percutaneous Coronary Intervention Registry, Oman.Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial InfarctionIn-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.Ventricular Assist Device in Acute Myocardial Infarction.Cardiogenic shock complicating myocardial infarction and outcome following percutaneous coronary intervention.Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.Percutaneous coronary intervention in cardiogenic shock complicating acute ST-elevation myocardial infarction-a single centre experience.Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction.Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease.Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States.Emerging drugs for acute myocardial infarction.High-risk percutaneous coronary intervention in the era of public reporting: clinical and ethical considerations in the care of an elderly patient with critical left main disease and shock.Shock in acute myocardial infarction: the Cape Horn for trials?Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis.Pathophysiology, diagnosis, and treatment of infarction-related cardiogenic shock.Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiCardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.Management of cardiogenic shock complicating acute coronary syndromes.Key recommendations and evidence from the NICE guideline for the acute management of ST-segment-elevation myocardial infarction.Therapeutic strategies for high-dose vasopressor-dependent shock.Management of cardiogenic shock.Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry.
P2860
Q24187672-86A54F9C-112B-492D-BB8E-556E83431A82Q24201225-C31CABD4-498C-4F44-A6AD-21D2B576A3ABQ24203783-25C2EDCC-0B49-4E48-9E7D-C2075937F46AQ26849912-F0A2EF85-7E96-49EC-A89C-644F1AA86C5BQ30252059-5E1A0000-1D10-48BF-B5FC-E9D459C0DC29Q30318082-D8C20E76-1609-4CA9-A8BB-7A6765B0210FQ31154746-1FF1D2DF-4AD7-4BE5-B4F3-41F5DF93E6E9Q33749994-3F4A0F37-C61A-4425-8739-E1A63C3DB0E2Q34179101-851775F5-5432-44AB-947B-CE32687AE9B6Q34317141-92968191-79F4-4DF9-8352-907390F39942Q34471018-1940607B-F05D-4BF2-955A-D81E7E79B891Q34497058-BD967EAC-09C9-4417-8284-6552F6AC1B37Q34613403-3C7E4A87-5D31-448A-AAD2-29D1C0FDCEE2Q34648000-32B470D8-CFE1-4923-9D7F-416F2EF125ABQ35060428-623E10BA-0C4D-4828-9EE2-D80AAA2AD616Q35675983-E5384443-B0B1-4CFF-A62D-F3BFF27F2043Q36485286-E1F82767-195D-4DB9-99CF-476470BCBA9CQ36634008-1B61AAF7-ADFE-41A1-9886-1BF21D4B6B08Q36693142-8574FEE7-9847-4219-BD81-015F61B21447Q36805340-AE477D24-63B3-477B-AE7B-334A6A79A9F9Q36827910-7E461E2F-E3DB-4A20-9023-4912A6CA7C8DQ37313224-0634BE75-C17B-49C7-ADED-D7C3AB816D44Q37315638-6D1BFE22-60AD-4924-B160-15BE6AA24607Q37387067-88BEDEFE-20CA-43DF-BAEB-BBCF4B4C7723Q37582213-16673E99-2088-4B44-8F00-DCEF2F2A5E42Q37619076-F7784011-28D4-4A61-8F16-4A4E4B62FBD0Q37648570-BD75379A-FD7F-43EA-82BD-30162DCC38F8Q37670190-45B0A709-4FE2-4700-AF11-A25A3E469102Q37732246-0D9E5664-47F6-4650-A3EC-E0574054C064Q37770822-067EFBB9-02E0-4B03-823A-575D4C40DF05Q37845021-DADE451A-9D53-4D37-84C4-B9CE0DCC7639Q37855618-0002ED79-2CD7-40D2-BEE1-80882DE451EEQ37886295-8CFC39CB-A247-4CEE-814A-3359CCB0C6F5Q37953885-4E2073EE-0329-40A6-8B8E-027B96C029C9Q37969891-E71750B5-327E-4D17-A78A-85B3F396822CQ38087313-40FA525D-C4E0-454A-AD64-BBFA5408B826Q38134682-AF841A2F-A5C5-4289-9F79-112E4127D0D8Q38154892-BEA7DD53-E97B-4F31-91E6-F234CB539676Q38366956-2D8AF231-B3A9-4667-8BAD-C892C92140CBQ38734235-167E3A6D-730B-499B-BAC3-D041458DAFDA
P2860
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Early revascularization and lo ...... ng acute myocardial infarction
@ast
Early revascularization and lo ...... ng acute myocardial infarction
@en
Early revascularization and lo ...... ng acute myocardial infarction
@nl
type
label
Early revascularization and lo ...... ng acute myocardial infarction
@ast
Early revascularization and lo ...... ng acute myocardial infarction
@en
Early revascularization and lo ...... ng acute myocardial infarction
@nl
prefLabel
Early revascularization and lo ...... ng acute myocardial infarction
@ast
Early revascularization and lo ...... ng acute myocardial infarction
@en
Early revascularization and lo ...... ng acute myocardial infarction
@nl
P2093
P2860
P921
P356
P1476
Early revascularization and lo ...... ng acute myocardial infarction
@en
P2093
Christopher E Buller
Harvey D White
Jacques Col
John G Webb
Lynn A Sleeper
Philip Aylward
SHOCK Investigators
Vladimir Dzavik
P2860
P304
P356
10.1001/JAMA.295.21.2511
P407
P577
2006-06-01T00:00:00Z